Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy

Muscle and Nerve

Volumn 43, Issue 6, 2011, Pages 780-794

  Bromberg, Mark B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic inflammatory demyelinating polyradicoloneuropathy; CIDP; Electrodiagnostic criteria; Nerve conduction; Neuropathy

Indexed keywords

ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; HUMAN; MOTOR NERVE CONDUCTION; NERVE CONDUCTION DISORDER; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SENSORY NERVE CONDUCTION;

ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 79957947361     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22038     Document Type: Review

References (58)

1. Dyck P, Lais A, Ohta M, Bastron J, Okazaki H, Groover R. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 1975;50: 621-636.
2. McLeod JG, Prineas JW, Walsh JC. The relationship of conduction velocity to pathology in peripheral nerves. In: Desmedt JE, editor. New developments in electromyography and clinical neurophysiology. Vol. 2. Basel: Karger; 1973. p 248-258.
3. Kelly J. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve 1983;6:504-509.
4. Lambert E. Neurophysiological techniques useful in the study of neuromuscular disorders. Res Publ Assoc Res Nerve Ment Dis 1960; 38:247-273.
5. Dyck P, Lambert E. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968;18:619-621.
6. Buchthal F, Behse F. Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 1977;100:41-66.
7. Albers J, Donofrio P, McGonagle T. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-539.
8. Albers J, Kelly J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12: 435-451.
9. Barohn R, Kissel J, Warmolts J, Mendell J. Chronic inflammatory demyelinating polyradiculoneuropathy. Arch Neurol 1989;46: 878-884.
10. AAN AHSot. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
11. Bromberg M. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991;14: 968-976.
12. Bromberg M, Jaros L. Symmetry of normal motor and sensory nerve conduction measurement. Muscle Nerve 1998;21:498-503.
13. Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000;57:1745-1750.
14. Hughes R, Bensa S, Willison H, van den Bergh P, Comi G, Illa I, Nobile-Orazio E, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50: 195-201.
15. Saperstein D, Katz J, Amato A, Barohn R. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-324.
16. Olney RK. Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999; 8(suppl):S225-229.
17. Oh S, Kim D, Kuruoglu H. What is the best diagnostic index of conduction block and temporal dispersion? Muscle Nerve 1994;17:489-493.
18. Nicolas G, Maisonobe T, Le Forestier N, Léger J-M, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26-30.
19. Thaisetthawatkul P, Logigian E, Herrmann D. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002;59:1526-1532.
20. Isose S, Kuwabara S, Kokubun N, Sato Y, Mori M, Shibuya K, et al. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst 2009; 14:151-158.
21. Stanton M, Pannoni V, Lewis RA, Logigian EL, Naguib D, Shy ME, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2006;34:417-422.
22. Magda P, Latov N, Brannagan TH III, Weimer LH, Chin RL, Sander HW. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2003;60:1755-1759.
23. van den Bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004;29:565-574.
24. Wilson J, Chawla J, Fisher M. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies. J Neurol Sci 2005;231:19-28.
25. Rajabally YA, Jacob S, Hbahbih M. Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases. J Peripher Nerv Syst 2005;10:282-292.
26. Rajabally YA, Jacob S. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2006;117:2079-2084.
27. van Asseldonk J, van den Berg, LH, Kalmijn, S, Wokke, JHJ, Franssen, H. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37_C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain 2005;128:880-891.
28. Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-332.
29. Viala K, Maisonobe T, Stojkovic T, Koutlidis R, Ayrignac X, Musset L, et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2010;15:50-56.
30. Tackenberg B, Lunemann JD, Steinbrecher A, Rothenfusser-Korber E, Sailer M, Bruck W, et al. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology 2007;68:1622-1629.
31. Koski CL, Baumgarten M, Magder LS, Barohn RJ, Goldstein J, Graves M, et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2009;277:1-8.
32. Rajabally YA, Nicolas G, Pieret F, Bouche P, van den Bergh PY. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009;80:1364-1368.
33. De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH III. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity. J Clin Neuromuscul Dis 2009;10:163-169.
34. Guidelines EPP. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2006;11:9-19.
35. EFNS/PNSR1. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 2010;15:1-9.
36. Murray N, Wade D. The sural sensory action potential in Guillain-Barré syndrome. Muscle Nerve 1980;3:444.
37. Bromberg M, Albers J. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 1993;16:262-266.
38. Tamura N, Kuwabara S, Misawa S, Mori M, Nakata M, Hattori T. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies. Clin Neurophysiol 2005;116:2330-2333.
39. Rajabally YA, Narasimhan M. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2007;118:1999-2004.
40. Bragg JA, Benatar MG. Sensory nerve conduction slowing is a specific marker for CIDP. Muscle Nerve 2008;38:1599-1603.
41. Rajabally YA, Samarasekera S. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2010;17:171-172.
42. Luciano C, Gilliatt R, Conwit R. Mixed nerve action potentials in acquired demyelinating polyneuropathy. Muscle Nerve 1995;18:85-92.
43. Tsukamoto H, Sonoo M, Shimizu T. Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDP. Clin Neurophysiol 2010;121:77-84.
44. Krarup C, Trojaborg W. Sensory pathophysiology in chronic acquired demyelinating neuropathy. Brain 1996;119:257-270.
45. Lewis R, Sumner A. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 1982;32:592-596.
46. Cornblath D, Kuncl R, Mellits E, Quaskey S, Clawson L, Pestronk A, et al. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 1992;15:1111-1115.
47. Latov N. Diagnosis of CIDP. Neurology 2002;59(suppl 6):S2-S6.
48. Campbell W, Robinson L. Deriving reference values in electrodiagnostic medicine. Muscle Nerve 1993;16:424-428.
49. Stetson DS, Albers JW, Silverstein BA, Wolfe RA. Effects of age, sex, and anthropometric factors on nerve conduction measures. Muscle Nerve 1992;15:1095-1104.
50. Rivner M, Swift T, Crout B, Rhodes K. Towards more rational nerve conduction interpretations: the effect of height. Muscle Nerve 1990; 13:232-239.
51. Puksa L, Stalberg E, Falck B. Reference values of F wave parameters in healthy subjects. Clin Neurophysiol 2003;114:1079-1090.
52. Notermans NC, Franssen H, Wieneke GH, Wokke JH. Temperature dependence of nerve conduction and EMG in neuropathy associated with gammopathy. Muscle Nerve 1994;17:516-522.
53. Franssen H, Wieneke, GH. Nerve conduction and temperature: necessary warming time. Muscle Nerve 1994;17:336-344.
54. Robinson L, Temkin N, Fujimoto W, Stolov W. Effects of statistical methodology on normal limits in nerve conduction studies. Muscle Nerve 1991;14:1084-1090.
55. Fisher MA, Hoffen B, Hultman C. Normative F wave values and the number of recorded F waves. Muscle Nerve 1994;17:1185-1189.
56. Panayiotopoulos CP, Chroni E. F-waves in clinical neurophysiology: a review, methodological issues and overall value in peripheral neuropathies. Electroencephalogr Clin Neurophysiol 1996;101:365-374.
57. Busch V, Schulte-Mattler WJ. Differentiation between uniform and non-uniform motor nerve conduction slowing. Clin Neurophysiol 2010;121:890-894.
58. van Dijk JG. Too many solutions for one problem. Muscle Nerve 2006;33:713-714.